AYRWF
Ayr Wellness Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · PNK
$0.02
Data: 2026-05-22
✗ ETHICAL FAIL
MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$2M
Total market value of the company
0.00
Rev Growth
-9.1%
Year-over-year revenue change
Profit Margin
-68.5%
How much profit the company keeps from each dollar of revenue
Analyst Target
N/A
Recommendation
N/A
Consensus view from ? analysts covering this stock
About Ayr Wellness Inc.
Company description not available.
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
35,273.2% FAIL
Debt must be below 33% of total assets
Cash Ratio
2,093.0% FAIL
Interest-bearing cash below 33% of assets
Receivables
0.0% PASS
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
Annual Return
-92.2%
Historical annualised return based on price data
Days in State
4
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
N/A
52W High
$N/A
52W Low
$N/A
Avg Volume
N/A
Average daily shares traded — higher means easier to buy and sell
Short % Float
N/A
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
Quick Ratio
N/A
Like current ratio but excludes inventory — stricter test
Gross Margin
N/A
Revenue left after cost of goods — higher means pricing power
Operating Margin
N/A
Profit from core operations before interest and tax
Revenue (TTM)
N/A
Total revenue over the last 12 months
Net Income
N/A
Loss-making — spending exceeds revenue after all costs
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2020-12-24 | Burggraeve (Chris Roger) | Director of Issuer | 1,000 | $22,740 | |
| 2020-12-23 | Isaacson (Glenn Howard) | Director of Issuer | 10,000 | $216,900 | |
| 2020-12-23 | Burggraeve (Chris Roger) | Director of Issuer | 500 | $11,000 | |
| 2020-12-23 | Burggraeve (Chris Roger) | Director of Issuer | 500 | $11,010 | |
| 2020-12-23 | Burggraeve (Chris Roger) | Director of Issuer | 500 | $11,095 | |
| 2020-12-23 | Isaacson (Glenn Howard) | Director of Issuer | 10,000 | $217,000 | |
| 2020-11-25 | Miles (Charles Edward) | Director of Issuer | 1,566 | $22,586 | |
| 2020-11-24 | Miles (Charles Edward) | Director of Issuer | 1,434 | $26,873 | |
| 2020-11-23 | Miles (Charles Edward) | Director of Issuer | 1,000 | $13,979 | |
| 2020-11-23 | Miles (Charles Edward) | Director of Issuer | 2,000 | $36,902 |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-22